Table 2.
Variable | Group N (n = 111) |
Group S (n = 35) |
Group H (n = 41) |
---|---|---|---|
Blood-stream infection | 27 (24.3) | 9 (25.7) | 17 (41.5)†§ |
Monomicrobial infection | 58 (52.3) | 19 (54.3) | 24 (58.5) |
Gram-negative monomicrobial infection | 27 (24.3) | 8 (22.9) | 22 (53.7)†§ |
Vibrio spp. | 19 (17.1) | 6 (17.1) | 15 (36.6)†§ |
Vibrio vulnificus | 17 (15.3) | 6 (17.1) | 14 (34.1)†§ |
Vibrio cholerae non-O1 | 1 (0.9) | 0 (0) | 1 (2.4) |
Vibrio parahaemolyticus | 1 (0.9) | 0 (0) | 0 (0) |
Aeromonas spp. | 4 (3.6) | 2 (5.7) | 4 (9.8) |
Aeromonas hydrophila | 4 (3.6) | 2 (5.7) | 3 (7.3) |
Aeromonas sobria | 0 (0) | 0 (0) | 1 (2.4) |
Enterobacter cloacae | 1 (0.9) | 0 (0) | 1 (2.4) |
Escherichia coli | 1 (0.9) | 0 (0) | 0 (0) |
Klebsiella pneumoniae | 1 (0.9) | 0 (0) | 0 (0) |
Pseudomonas aeruginosa | 1 (0.9) | 0 (0) | 1 (2.4) |
Shewanella putrefaciens | 0 (0) | 0 (0) | 1 (2.4) |
Gram-positive monomicrobial infection | 31 (27.9) | 11 (31.4) | 2 (4.9)†§ |
Staphylococcus spp. | 22 (19.8) | 5 (14.3) | 2 (4.9)† |
MRSAa | 12 (10.8) | 2 (5.7) | 1 (2.4) |
MSSAb | 9 (8.1) | 2 (5.7) | 1 (2.4) |
Coagulase-negative staphylcoccus | 1 (0.9) | 1 (2.9) | 0 (0) |
Streptococcus spp. | 9 (8.1) | 6 (17.1) | 0 (0)§ |
Streptococcus species | 3 (2.7) | 0 (0) | 0 (0) |
Streptococcus group non-ABD | 2 (1.8) | 2 (5.7) | 0 (0) |
Streptococcus pyogenes | 1 (0.9) | 1 (2.9) | 0 (0) |
Streptococcus agalactiae | 1 (0.9) | 1 (2.9) | 0 (0) |
Streptococcus dysgalactiae subsp. equisimilis | 1 (0.9) | 2 (5.7) | 0 (0) |
Anaerobic bacteria | |||
Peptostreptococcus sp | 1 (0.9) | 0 (0) | 0 (0) |
Polymicrobial infection | 22 (19.8) | 3 (8.6) | 12 (29.3)§ |
Culture-negative necrotizing fasciitis | 31 (27.9) | 13 (37.1) | 5 (12.2)†§ |
Abbreviations: aMRSA methicillin-resistant Staphylococcus aureus, bMSSA methicillin-sensitive Staphylococcus aureus
Data were presented as frequency (%).; Data were compared with ANOVA, †p < 0.05 vs. no bullae in the Tukey post hoc test; §p < 0.05 vs. serious bullae in the Tukey post hoc test